Characterizing the subtype of anhedonia in major depressive disorder: a symptom-specific multimodal MRI study

Author(s):  
Xiaodan Liu ◽  
Lingsheng Li ◽  
Meng Li ◽  
Zepu Ren ◽  
Ping Ma
2011 ◽  
Vol 124 (6) ◽  
pp. 435-446 ◽  
Author(s):  
Hanna Järnum ◽  
Simon F. Eskildsen ◽  
Elena G. Steffensen ◽  
Søren Lundbye-Christensen ◽  
Carsten W. Simonsen ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Jin Liu ◽  
Bangshan Liu ◽  
Mi Wang ◽  
Yumeng Ju ◽  
Qiangli Dong ◽  
...  

Background: Cognitive deficits have shown progressive feature in major depressive disorder (MDD). However, it remains unknown which component of cognitive function is progressively impaired across episodes of MDD. Here we aim to identify the progressively impaired cognitive components in patients with MDD.Methods: A comprehensive neurocognitive test battery was used to assess the cognitive components (executive function, attention, processing speed, memory, working memory, inhibition, shifting, and verbal fluency) in 35 patients with first-episode MDD (FED), 60 patients with recurrent MDD (RD) and 111 matched healthy controls (HCs). After 6 months of treatment with antidepressant, 20 FED and 36 RD patients achieved clinical remission and completed their second-time neurocognitive tests. Statistical analyses were conducted to identify the impaired cognitive components in the FED and RD groups before and after treatment, and to assess the relationship between the cognitive components and the number of episodes and total illness duration in the MDD patient group.Results: At baseline, both the FED and RD groups showed impairments in all of the cognitive components; the FED and RD groups showed no significant difference in all of the components except for shifting. After remission, only shifting in the RD group showed no significant improvement and remained in an impaired status. Furthermore, shifting was the only component negatively correlated with the number of episodes as well as the total illness duration.Conclusions: Shifting may serve as the progressive cognitive deficit across episodes of MDD.Clinical Trials Registration: Registry name: HPA function and MRI study of trauma-related depression; Registration number: ChiCTR1800014591; URL: http://www.chictr.org.cn/edit.aspx?pid=24669&htm=4.


2003 ◽  
Vol 124 (3) ◽  
pp. 129-140 ◽  
Author(s):  
Acioly L.T. Lacerda ◽  
Mark A. Nicoletti ◽  
Paolo Brambilla ◽  
Roberto B. Sassi ◽  
Alan G. Mallinger ◽  
...  

2019 ◽  
Vol 111 ◽  
pp. 186-192 ◽  
Author(s):  
John W. Rutland ◽  
Stephanie Brown ◽  
Gaurav Verma ◽  
Rebecca E. Feldman ◽  
Himanshu Sharma ◽  
...  

2019 ◽  
Author(s):  
Mingrui Xia ◽  
Tianmei Si ◽  
Xiaoyi Sun ◽  
Qing Ma ◽  
Bangshan Liu ◽  
...  

AbstractResting-state functional MRI (R-fMRI) studies have demonstrated widespread alterations in brain function in patients with major depressive disorder (MDD). However, a clear and consistent conclusion regarding a repeatable pattern of MDD-relevant alterations is still limited due to the scarcity of large-sample, multisite datasets. Here, we address this issue by including a large R-fMRI dataset with 1,434 participants (709 patients with MDD and 725 healthy controls) from five centers in China. Individual functional activity maps that represent very local to long-range connections are computed using the amplitude of low-frequency fluctuations, regional homogeneity and distance-related functional connectivity strength. The reproducibility analyses involve different statistical strategies, global signal regression, across-center consistency, clinical variables, and sample size. We observed significant hypoactivity in the orbitofrontal, sensorimotor, and visual cortices and hyperactivity in the frontoparietal cortices in MDD patients compared to the controls. These alterations are not affected by different statistical analysis strategies, global signal regression and medication status and are generally reproducible across centers. However, these between-group differences are partially influenced by the episode status and the age of disease onset in patients, and the brain-clinical variable relationship exhibits poor cross-center reproducibility. Bootstrap analyses reveal that at least 400 subjects in each group are required to replicate significant alterations (an extent threshold of P<.05 and a height threshold of P<.001) at 50% reproducibility. Together, these results highlight reproducible patterns of functional alterations in MDD and relevant influencing factors, which provides crucial guidance for future neuroimaging studies of this disorder.


Sign in / Sign up

Export Citation Format

Share Document